Rapport Therapeutics, Inc.
RAPP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002012593
In the last 90 days, Rapport Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Rapport Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +35 vs. Q1 2024
- Shares held
- 25.6M
- +25.6M vs. Q1 2024
- Total value
- $593.4M
- +$593.4M vs. Q1 2024
- New holders
- 35
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RAPP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 160 | $2.13B |
| Q1 2026 | 147 | $1.64B |
| Q4 2025 | 144 | $1.56B |
| Q3 2025 | 124 | $1.46B |
| Q2 2025 | 82 | $437.9M |
| Q1 2025 | 77 | $382.3M |
| Q4 2024 | 70 | $648.9M |
| Q3 2024 | 55 | $582.0M |
| Q2 2024 | 35 | $593.4M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Rapport Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 4,983,351 | $115.9M | 0.01% | +4,983,351 | New |
| ARCH Venture Management, LLC | 3,728,738 | $86.7M | 32.60% | +3,728,738 | New |
| Cormorant Asset Management, LP | 2,940,283 | $68.4M | 3.98% | +2,940,283 | New |
| Capital International Investors | 2,602,531 | $60.5M | 0.01% | +2,602,531 | New |
| Johnson & Johnson | 2,498,051 | $58.1M | 14.50% | +2,498,051 | New |
| Sofinnova Investments, Inc. | 1,951,562 | $45.4M | 2.86% | +1,951,562 | New |
| T. Rowe Price Investment Management, Inc. | 1,535,151 | $35.7M | 0.02% | +1,535,151 | New |
| Price T Rowe Associates Inc | 1,360,605 | $31.6M | 0.00% | +1,360,605 | New |
| Alliancebernstein L.P. | 1,090,858 | $25.4M | 0.01% | +1,090,858 | New |
| Perceptive Advisors LLC | 748,183 | $17.4M | 0.42% | +748,183 | New |
| Citadel Advisors LLC | 592,458 | $13.2M | 0.01% | +592,458 | New |
| Artal Group S.A. | 350,000 | $8.14M | 0.21% | +350,000 | New |
| Logos Global Management LP | 208,910 | $4.37M | 0.50% | +208,910 | New |
| Woodline Partners LP | 171,100 | $3.98M | 0.04% | +171,100 | New |
| Millennium Management LLC | 116,782 | $2.72M | 0.00% | +116,782 | New |
| TD Asset Management Inc | 101,522 | $2.36M | 0.00% | +101,522 | New |
| Manufacturers Life Insurance Company, The | 75,516 | $1.76M | 0.00% | +75,516 | New |
| Vanguard Group Inc | 70,000 | $1.63M | 0.00% | +70,000 | New |
| Norges Bank | 70,000 | $1.63M | 0.00% | +70,000 | New |
| Saturn V Capital Management LLC | 70,000 | $1.63M | 0.62% | +70,000 | New |
| Eventide Asset Management, LLC | 50,000 | $1.16M | 0.02% | +50,000 | New |
| LMR Partners LLP | 50,000 | $1.16M | 0.02% | +50,000 | New |
| Monashee Investment Management LLC | 40,000 | $930.4K | 0.12% | +40,000 | New |
| Alyeska Investment Group, L.P. | 34,731 | $807.8K | 0.00% | +34,731 | New |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 30,000 | $697.8K | 0.02% | +30,000 | New |
| Acuta Capital Partners, LLC | 20,000 | $465.2K | 0.39% | +20,000 | New |
| Squarepoint Ops LLC | 16,345 | $380.2K | 0.00% | +16,345 | New |
| Two Sigma Investments, LP | 13,000 | $302.4K | 0.00% | +13,000 | New |
| Balyasny Asset Management LLC | 10,000 | $232.6K | 0.00% | +10,000 | New |
| Davidson Kempner Capital Management LP | 10,000 | $228.6K | 0.00% | +10,000 | New |
| Barclays PLC | 9,400 | $218.6K | 0.00% | +9,400 | New |
| Sandia Investment Management LP | 5,000 | $116.3K | 0.15% | +5,000 | New |
| UBS Group AG | 3,127 | $72.7K | 0.00% | +3,127 | New |
| Tidemark, LLC | 1,088 | $25.3K | 0.01% | +1,088 | New |
| Royal Bank of Canada | 225 | $5.00K | 0.00% | +225 | New |